Sfoglia per AUTORE
GORI S
Collezione ASL Biella

  

Items : 5

The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies in Critical Reviews in Oncology/Hematology

2022
ASL Biella

Russo A; Incorvaia L; Capoluongo E; Tagliaferri P; Galvano A; Del Re M; Malapelle U; Chiari R; Conte P; Danesi R; Fassan M; Ferrara R; Genuardi M; Ghiorzo P; Gori S; Guadagni F; Marchetti A; Marchetti P; Midiri M; Normanno N; Passiglia F; Pinto C; Silvestris N; Tallini G; Vatrano S; Vincenzi B; Cinieri S; Beretta G;

Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer - TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088). in Trials / Trials. 2020 Jul 25;21(1):678. doi: 10.1186/s13063-020-04568-9.

2020
AOU Alessandria
ASL Biella

Torri V; Orecchia S; Fusco V; Traverso E; Solaini L; Ercolani G; Cavaliere D; Buccianti P; Balestri R; Ceccarelli C; Coratti A; Menegatti B; Perna F; Contardo T; Mammano E; Morpurgo E; Pulighe F; De Nisco C; Pernazza G; Ruffo G; Alongi F; Bertocchi E; Gori S; Perinotti R; Rosati R; Delpini R; Boni L; Elmore U; Baldari L; et alii...

Correction to: Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2020 Feb 17;20(1):128. doi: 10.1186/s12885-020-6632-y.

2020
ASL Biella
AOU Alessandria
AOU Novara

Franzone P; Numico G; Priora F; Rossi M; Fusco V; Traverso E; Torri V; Cavaliere D; Solaini L; Ercolani G; Ceccarelli C; Balestri R; Buccianti P; Baroffio P; Gentilli S; Menegatti B; Coratti A; Perna F; Rosati R; Delpini R; Elmore U; Mammano E; Contardo T; Morpurgo E; Perinotti R; De Nisco C; Pulighe F; Pernazza G; Boni L; et alii...

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis. in The oncologist / Oncologist. 2019 Mar;24(3):385-393. doi: 10.1634/theoncologist.2018-0442. Epub 2019 Jan 3.

2019
ASL Biella

Di Bartolomeo M; Galli F; Dotti KF; Antista M; Aglietta M; Cinieri S; Faedi M; Gori S; Cavanna L; Ciarlo A; Barni S; Leonardi F; Giordani P; Clerico M; Adamo V; Tamburini E; Re GL; Ferrario S; Buonadonna A; Tronconi MC; Pavesi L; Frassineti GL; Nicolini M; Rosati G; Labianca RF; Bidoli P; Ferrari D; Banzi M; Damiani A; et alii...

Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2019 Dec 16;19(1):1215. doi: 10.1186/s12885-019-6271-3.

2019
ASL Biella
AOU Alessandria
AOU Novara

Orecchia S; Numico G; Franzone P; Priora F; Rossi M; Fusco V; Traverso E; Ercolani G; Cavaliere D; Solaini L; Torri V; Ceccarelli C; Buccianti P; Balestri R; Menegatti B; Gentilli S; Baroffio P; Perna F; Coratti A; Delpini R; Rosati R; Elmore U; Mammano E; Pulighe F; De Nisco C; Perinotti R; Morpurgo E; Boni L; Contardo T; et alii...